Nautilus Biotechnology, Inc. (NAUT)
1.96
-0.10
(-4.85%)
USD |
NASDAQ |
Jan 12, 11:40
Nautilus Biotechnology EPS Diluted (Quarterly): -0.1075 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Sensus Healthcare, Inc. | -0.0578 |
| GoodRx Holdings, Inc. | 0.0032 |
| Prelude Therapeutics, Inc. | -0.2591 |
| ProKidney Corp. | -0.122 |
| Neumora Therapeutics, Inc. | -0.3507 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -13.57M |
| Total Expenses (Quarterly) | 13.57M |
| Enterprise Value | 155.76M |
| Earnings Yield | -25.42% |
| Normalized Earnings Yield | -25.42 |